Literature DB >> 30973597

Primary Resistance to Immune Checkpoint Inhibitors in Metastatic Colorectal Cancer-Beyond the Misdiagnosis.

Vassiliki Kotoula1, Florentia Fostira2, Elena Fountzilas3.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30973597     DOI： 10.1001/jamaoncol.2019.0521

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  2 in total

1.  LncRNA ARST is a Novel Prognostic and Diagnostic Biomarker for Colorectal Cancer.

Authors:  Lujia Dong; Di Liu; Dongshuai Jing; Huihui Xu; Chenxiao Zhang; Donglei Qi; Dechun Liu
Journal:  Cancer Manag Res       Date:  2022-01-03       Impact factor: 3.989

2.  Association between body mass index and survival outcomes for cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis.

Authors:  Yue An; Zhonghua Wu; Ningning Wang; Zhidong Yang; Yue Li; Boyang Xu; Mingjun Sun
Journal:  J Transl Med       Date:  2020-06-12       Impact factor: 5.531
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.